search
Back to results

Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design (PS)

Primary Purpose

Crestal Bone Loss

Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Platform Matched Design (Group A)
Platform Switching Design (Group B)
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Crestal Bone Loss focused on measuring platform switching, dental implant, crestal bone level, implant stability, postoperative complication

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Patients older than18 yrs.
  2. Patients with missing teeth in the posterior maxilla (from the 1st premolar to 2nd Molar) bilaterally in need for fixed implant-supported prosthesis.
  3. Full mouth plaque score and full mouth bleeding score ˂25 %
  4. Patients with adequate bone quality and quantity at the implant site
  5. Patients with systematic healthy.
  6. Non-smokers or those smoking ˂10 cigarettes/day
  7. Patients who were cooperative, motivated, and hygiene conscious and willing to return for multiple follow-up appointments (up to 9 months after prosthetic loading).

Exclusion Criteria:

I) General:-

  1. Patients with any systemic condition that may contraindicate implant therapy.
  2. Patients with a history of Bisphosphonate therapy
  3. Pregnant and lactating patients
  4. Alcohol and drug abuse
  5. Parafunctional habits that produce overload on the implant such as bruxism and clenching.

II) Local:-

  1. Local inflammation or infection at implant site.
  2. Untreated periodontitis
  3. Local irradiation therapy
  4. History of implant failure as well as unhealed extraction socket
  5. Inadequate keratinized gingiva or thin gingival biotype.
  6. Inadequate bone height or width.
  7. Insufficient vertical inter-arch space, upon centric occlusion, to accommodate the available restorative components.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    Group A (Platform Matched Design)

    Group B (intervention - Platform Switching Design)

    Arm Description

    10 Patients with missing tooth in upper posterior area will receive dental implant (implants with the same abutment diameter)

    10 patients with missing tooth in upper posterior area will receive dental implant (implants with smaller diameter abutment)

    Outcomes

    Primary Outcome Measures

    crestal bone loss
    assessment crestal bone loss after 9 months after crown placement

    Secondary Outcome Measures

    implant stability
    assessment implant placement by periotest at abutment instillation and after 9 month of crown placement

    Full Information

    First Posted
    April 5, 2016
    Last Updated
    May 6, 2016
    Sponsor
    Cairo University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02761226
    Brief Title
    Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design
    Acronym
    PS
    Official Title
    Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design (Randomized Clinical Trial, Split Mouth Design)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2015 (undefined)
    Primary Completion Date
    May 2016 (Actual)
    Study Completion Date
    May 2016 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cairo University

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Implants have become the preferred method of single tooth replacement these days, patients receiving implant treatments not only expect restoration of masticatory function, they also expect that the prostheses will be esthetically pleasing, easy to clean, and permanent. To maintain long-term implant stability, it is important to minimize bone loss around the implant, as well as the soft tissue atrophy that accompanies it.
    Detailed Description
    The peri-implant bone level has been used as one of the criteria to assess the success of dental implants, Platform switching (PLS) for maintaining peri-implant bone levels has gained popularity among implant manufacturers over the last few years. However, the assumption that the inward shifting of the implant- abutment junction may preserve crestal bone was primarily based on serendipitous finding rather than scientific evidence. It is known that saucerization around an implant occurs following abutment connection using a submerged implant with a butt joint (a two-stage approach), such as the Branemark implant. The nature of saucerization varies according to implant type (one-stage or two-stage) and abutment connection type. they have reported that the factors that are the most likely causes of early crestal bone loss around implants are: The micro-gap, The implant crest module, Occlusal overload, and The biologic width around the dental implant. At the Toronto Conference 1998, the consensus with respect to bone loss around the implant was that bone loss of up to approximately 2 mm during the first year of implant function is acceptable, and at this level the implant is regarded as successful. There have been many reports on studies to ascertain the causes of bone loss around implants and clinical techniques to prevent it. Some reports published in 2005 and 2006 state that the platform switching technique, a technique in which an abutment that is one-size smaller than the implant platform is placed, prevents bone loss around the implant. However, there are only a few reports on the mechanism of action or the extent of bone loss prevention, and as such, it is difficult to say that the effect of PLS has been thoroughly examined. This review article examines the PLS technique and the bone loss preventive effect. A lot of clinical studies discussed the concept of platform switching was extensively studied histologically and biomechanically. In histomorphometric studies in dogs was no significant difference in the marginal bone level around platform- switched and -matched implants after 28 days of healing. In contrast, other studies reported a significantly less bone loss around platform-switched implants after a loading period of 2 to 6months. However, there is no consistency among the studies with respect to the study design (e.g. the location and depth of the implant, and controlled/non-controlled), and as such, it is difficult to evaluate all of these studies using the same evaluation method. The review and meta-analysis show that platform switching may preserve interimplant bone height and soft tissue levels. The degree of marginal bone resorption is inversely related to the extent of the implant- abutment mismatch. But still no general agreement to confirm the validity of this concept, so Further long-term, well-conducted, randomized controlled studies are needed to confirm the validity of this concept.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Crestal Bone Loss
    Keywords
    platform switching, dental implant, crestal bone level, implant stability, postoperative complication

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Phase 2
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    10 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Group A (Platform Matched Design)
    Arm Type
    Experimental
    Arm Description
    10 Patients with missing tooth in upper posterior area will receive dental implant (implants with the same abutment diameter)
    Arm Title
    Group B (intervention - Platform Switching Design)
    Arm Type
    Active Comparator
    Arm Description
    10 patients with missing tooth in upper posterior area will receive dental implant (implants with smaller diameter abutment)
    Intervention Type
    Procedure
    Intervention Name(s)
    Platform Matched Design (Group A)
    Other Intervention Name(s)
    group 1
    Intervention Description
    10 patients with missing upper posterior teeth will receive dental implant with platform matched design (the patients will receive implant 4.2mm with same abutment diameter 4.2mm)
    Intervention Type
    Procedure
    Intervention Name(s)
    Platform Switching Design (Group B)
    Other Intervention Name(s)
    group 2
    Intervention Description
    10 patients with missing upper posterior teeth will receive dental implant with platform switching design(the patients will receive implant 4.2mm with smaller abutment diameter 3.5 mm
    Primary Outcome Measure Information:
    Title
    crestal bone loss
    Description
    assessment crestal bone loss after 9 months after crown placement
    Time Frame
    9 months
    Secondary Outcome Measure Information:
    Title
    implant stability
    Description
    assessment implant placement by periotest at abutment instillation and after 9 month of crown placement
    Time Frame
    9 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    60 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Patients older than18 yrs. Patients with missing teeth in the posterior maxilla (from the 1st premolar to 2nd Molar) bilaterally in need for fixed implant-supported prosthesis. Full mouth plaque score and full mouth bleeding score ˂25 % Patients with adequate bone quality and quantity at the implant site Patients with systematic healthy. Non-smokers or those smoking ˂10 cigarettes/day Patients who were cooperative, motivated, and hygiene conscious and willing to return for multiple follow-up appointments (up to 9 months after prosthetic loading). Exclusion Criteria: I) General:- Patients with any systemic condition that may contraindicate implant therapy. Patients with a history of Bisphosphonate therapy Pregnant and lactating patients Alcohol and drug abuse Parafunctional habits that produce overload on the implant such as bruxism and clenching. II) Local:- Local inflammation or infection at implant site. Untreated periodontitis Local irradiation therapy History of implant failure as well as unhealed extraction socket Inadequate keratinized gingiva or thin gingival biotype. Inadequate bone height or width. Insufficient vertical inter-arch space, upon centric occlusion, to accommodate the available restorative components.

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Clinical and Radiographic Evaluation of Crestal Bone Loss Around Implant With or Without Platform Switching Design

    We'll reach out to this number within 24 hrs